Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,513 | -53,180 | -40,455 | -51,745 | -30,427 |
| Depreciation Amortization | 2,445 | 1,572 | 725 | 1,561 | 1,362 |
| Accounts receivable | -38,838 | -27,604 | -1,152 | -31,648 | -19,330 |
| Accounts payable and accrued liabilities | 33,363 | 30,462 | 27,844 | 12,432 | 3,128 |
| Other Working Capital | 6,683 | -14,284 | 12,028 | -60,530 | -39,222 |
| Other Operating Activity | 22,524 | 8,984 | -21,618 | 106,276 | 95,787 |
| Operating Cash Flow | $-58,336 | $-54,050 | $-22,628 | $-23,654 | $11,298 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -317 | -317 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-317 | $-317 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 245,102 | N/A |
| Debt Repayment | N/A | N/A | N/A | -210,088 | N/A |
| Common Stock Issued | 13,522 | 2,850 | 0 | 106,022 | 106,040 |
| Other Financing Activity | -7,500 | -7,500 | -7,500 | -54,552 | -54,552 |
| Financing Cash Flow | $6,022 | $-4,650 | $-7,500 | $86,484 | $51,488 |
| Beginning Cash Position | 144,761 | 144,761 | 144,761 | 82,248 | 82,248 |
| End Cash Position | 92,447 | 86,061 | 114,633 | 144,761 | 144,717 |
| Net Cash Flow | $-52,314 | $-58,700 | $-30,128 | $62,513 | $62,469 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,336 | -54,050 | -22,628 | -23,654 | 11,298 |
| Capital Expenditure | N/A | N/A | 0 | -317 | -317 |
| Free Cash Flow | -58,336 | -54,050 | -22,628 | -23,971 | 10,981 |